Richard Aguilar, Chief Clinical Officer at Cano Health, Inc. (CANO), bought 24,777 shares at $10.75 ($266K) on 2021-08-30, disclosed to the SEC on 2021-09-14.
Open-market purchase of $266k CANO by Chief Clinical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| CANO | SELL | 2023-04-06 | $0 | — | Filing → |
| CANO | BUY | 2021-09-01 | $21K | — | Filing → |
| CANO | BUY | 2021-08-31 | $10.0M | — | Filing → |